Literature DB >> 19926338

Eosinophils and allergic airway disease: there is more to the story.

Elizabeth R Walsh1, Avery August.   

Abstract

The eosinophil has been perceived as a terminal effector cell in allergic airway diseases. However, recent work has shown that this multifunctional cell could be more involved in the initial stages of allergic disease development than was previously thought, particularly with regard to the ability of the eosinophil to modulate T-cell responses. In this review, we discuss recent advances that suggest that eosinophils can present antigen to naïve as well as to antigen-experienced T cells, induce T helper 2 cell development, cytokine production or both, and affect T-cell migration to sites of inflammation. These findings are changing the way that eosinophil function in disease is perceived, and represent a shift in the dogma of allergic disease development.

Entities:  

Mesh:

Year:  2009        PMID: 19926338      PMCID: PMC2846296          DOI: 10.1016/j.it.2009.10.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  57 in total

1.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.

Authors:  Steffen Jung; Derya Unutmaz; Phillip Wong; Gen-Ichiro Sano; Kenia De los Santos; Tim Sparwasser; Shengji Wu; Sri Vuthoori; Kyung Ko; Fidel Zavala; Eric G Pamer; Dan R Littman; Richard A Lang
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

2.  Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet.

Authors:  Susetta Finotto; Markus F Neurath; Jonathan N Glickman; Shixin Qin; Hans A Lehr; Francis H Y Green; Kate Ackerman; Kathleen Haley; Peter R Galle; Susanne J Szabo; Jeffrey M Drazen; George T De Sanctis; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

3.  Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma.

Authors:  C L Karp; A Grupe; E Schadt; S L Ewart; M Keane-Moore; P J Cuomo; J Köhl; L Wahl; D Kuperman; S Germer; D Aud; G Peltz; M Wills-Karp
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

4.  Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function.

Authors:  J R MacKenzie; J Mattes; L A Dent; P S Foster
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

5.  CD11c+ eosinophils in the murine thymus: developmental regulation and recruitment upon MHC class I-restricted thymocyte deletion.

Authors:  M Throsby; A Herbelin; J M Pléau; M Dardenne
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

Review 6.  Chemokines in asthma: cooperative interaction between chemokines and IL-13.

Authors:  Nives Zimmermann; Gurjit Khurana Hershey; Paul S Foster; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

7.  CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo.

Authors:  C M Lloyd; T Delaney; T Nguyen; J Tian; C Martinez-A; A J Coyle; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

8.  Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo.

Authors:  Channing Yu; Alan B Cantor; Haidi Yang; Carol Browne; Richard A Wells; Yuko Fujiwara; Stuart H Orkin
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

9.  Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.

Authors:  Joerg Mattes; Ming Yang; Surendran Mahalingam; Joachim Kuehr; Dianne C Webb; Ljubov Simson; Simon P Hogan; Aulikki Koskinen; Andrew N J McKenzie; Lindsay A Dent; Marc E Rothenberg; Klaus I Matthaei; Ian G Young; Paul S Foster
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

10.  Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.

Authors:  D B Corry; H G Folkesson; M L Warnock; D J Erle; M A Matthay; J P Wiener-Kronish; R M Locksley
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  16 in total

1.  Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up Study.

Authors:  Elizabeth A Platz; Charles G Drake; Kathryn M Wilson; Siobhan Sutcliffe; Stacey A Kenfield; Lorelei A Mucci; Meir J Stampfer; Walter C Willett; Carlos A Camargo; Edward Giovannucci
Journal:  Int J Cancer       Date:  2015-02-27       Impact factor: 7.396

2.  Regulation of Eosinophil Recruitment and Allergic Airway Inflammation by Tropomyosin Receptor Kinase A.

Authors:  Mythili Dileepan; Xiao Na Ge; Idil Bastan; Yana G Greenberg; Yuying Liang; P Sriramarao; Savita P Rao
Journal:  J Immunol       Date:  2019-12-23       Impact factor: 5.422

3.  Peptidoglycan recognition protein 1 promotes house dust mite-induced airway inflammation in mice.

Authors:  Xianglan Yao; Meixia Gao; Cuilian Dai; Katharine S Meyer; Jichun Chen; Karen J Keeran; Gayle Z Nugent; Xuan Qu; Zu-Xi Yu; Pradeep K Dagur; J Philip McCoy; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

Review 4.  What targeting eosinophils has taught us about their role in diseases.

Authors:  Bruce S Bochner; Gerald J Gleich
Journal:  J Allergy Clin Immunol       Date:  2010-07       Impact factor: 10.793

Review 5.  Eosinophilic chronic rhinosinusitis in East Asians.

Authors:  En-Tong Wang; Yan Zheng; Peng-Fei Liu; Li-Juan Guo
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

6.  Tumour-Associated Tissue Eosinophilia in Oral Squamous Cell Carcinoma- A Boon or a Bane?

Authors:  Shweta Yellapurkar; Srikant Natarajan; Karen Boaz; Mohan Baliga; Premalatha Shetty; Nidhi Manaktala; Mukul Prasad; Mahalakshmi Ravi
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 7.  Complement components as potential therapeutic targets for asthma treatment.

Authors:  Mohammad Afzal Khan; Mark R Nicolls; Besiki Surguladze; Ismail Saadoun
Journal:  Respir Med       Date:  2014-01-15       Impact factor: 3.415

8.  Infection, eosinophilia and childhood asthma.

Authors:  Chang-Keun Kim; Zak Callaway; Takao Fujisawa
Journal:  Asia Pac Allergy       Date:  2012-01-31

9.  IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro.

Authors:  Nicola M Heller; William M Gwinn; Raymond P Donnelly; Stephanie L Constant; Achsah D Keegan
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

10.  Assessment of murine lung mechanics outcome measures: alignment with those made in asthmatics.

Authors:  Julia K L Walker; Monica Kraft; John T Fisher
Journal:  Front Physiol       Date:  2013-02-12       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.